PROCEPT BioRobotics -Procept BioRobotics outlines $410M–$430M 2026 revenue target while accelerating utilization initiatives (NASDAQ:PRCT)

Procept BioRobotics outlines $410M–$430M 2026 revenue target while accelerating utilization initiatives (NASDAQ:PRCT)

PROCEPT BioRobotics (US:PRCT) Seeking Alpha·2025-11-05 10:36

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...